CLINICAL_TRIALS
trial_result
· 2017-03-27
Clinical Trial Update: Safety and Tolerability Study of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia [Phase 3]
Summary
Phase 3 safety and tolerability study of oral OPC-34712 as maintenance treatment in adults with schizophrenia has completed and results were posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED | Results posted: 2017-03-27